{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:50:06Z","timestamp":1773273006851,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,9,9]],"date-time":"2010-09-09T00:00:00Z","timestamp":1283990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/bf03347076","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T08:41:52Z","timestamp":1396428112000},"page":"e52-e57","source":"Crossref","is-referenced-by-count":7,"title":["Serum thyroxine and age \u2014 rather than thyroid volume and serum TSH \u2014 are determinants of the thyroid radioiodine uptake in patients with nodular goiter"],"prefix":"10.1007","volume":"34","author":[{"given":"S. J.","family":"Bonnema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Fast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. E.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Boel-Jorgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Grupe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. B.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Heged\u00fcs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,9]]},"reference":[{"key":"BF03347076_CR1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0016","volume":"24","author":"L Heged\u00fcs","year":"2003","unstructured":"Heged\u00fcs L, Bonnema SJ, Bennedb\u00e6k FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev 2003, 24: 102\u201332.","journal-title":"Endocr Rev"},{"key":"BF03347076_CR2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/jcem.86.3.7244","volume":"86","author":"MF Wesche","year":"2001","unstructured":"Wesche MF, Tiel-Van Buul MM, Lips P, Smits NJ, Wiersinga WM. A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab 2001, 86: 998\u20131005.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347076_CR3","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/bmj.307.6908.828","volume":"307","author":"B Nygaard","year":"1993","unstructured":"Nygaard B, Heged\u00fcs L, Gervil M, Hjalgrim H, S\u00f8e-Jensen P, Hansen JM. Radioiodine treatment of multinodular non-toxic goitre. BMJ 1993, 307: 828\u201332.","journal-title":"BMJ"},{"key":"BF03347076_CR4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1046\/j.1365-2265.1999.00734.x","volume":"50","author":"R Moli Le","year":"1999","unstructured":"Le Moli R, Wesche MF, Tiel-Van Buul MM, Wiersinga WM. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre. Clin Endocrinol (Oxf) 1999, 50: 783\u20139.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03347076_CR5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7326\/0003-4819-121-10-199411150-00005","volume":"121","author":"DA Huysmans","year":"1994","unstructured":"Huysmans DA, Hermus AR, Corstens FH, Barentsz JO, Kloppenborg PW. Large, compressive goiters treated with radioiodine. Ann Intern Med 1994, 121: 757\u201362.","journal-title":"Ann Intern Med"},{"key":"BF03347076_CR6","first-page":"36","volume":"84","author":"SJ Bonnema","year":"1999","unstructured":"Bonnema SJ, Bertelsen H, Mortensen J, et al. The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. J Clin Endocrinol Metab 1999, 84: 36\u201341.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347076_CR7","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1590\/S0100-879X2006005000186","volume":"40","author":"GJ Paz-Filho","year":"2007","unstructured":"Paz-Filho GJ, Mesa-Junior CO, Olandoski M, et al. Effect of 30 mCi radioiodine on multinodular goiter previously treated with recombinant human thyroid-stimulating hormone. Braz J Med Biol Res 2007, 40: 1661\u201370.","journal-title":"Braz J Med Biol Res"},{"key":"BF03347076_CR8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1530\/eje.1.02094","volume":"154","author":"O Cohen","year":"2006","unstructured":"Cohen O, Ilany J, Hoffman C, et al. Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients. Eur J Endocrinol 2006, 154: 243\u201352.","journal-title":"Eur J Endocrinol"},{"key":"BF03347076_CR9","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1210\/jc.2004-0458","volume":"90","author":"CC Albino","year":"2005","unstructured":"Albino CC, Mesa CO Jr, Olandoski M, et al. Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine. J Clin Endocrinol Metab 2005, 90: 2775\u201380.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347076_CR10","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1210\/jc.2002-021554","volume":"88","author":"WA Nieuwlaat","year":"2003","unstructured":"Nieuwlaat WA, Huysmans DA, Van Den Bosch HC, et al. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J Clin Endocrinol Metab 2003, 88: 3121\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347076_CR11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1365-2265.2003.01918.x","volume":"60","author":"MN Silva","year":"2004","unstructured":"Silva MN, Rubio IG, Romao R, et al. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres. Clin Endocrinol (Oxf) 2004, 60: 300\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03347076_CR12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1530\/EJE-08-0779","volume":"160","author":"S Fast","year":"2009","unstructured":"Fast S, Nielsen VE, Bonnema SJ, Hegedus L. Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy. Eur J Endocrinol 2009, 160: 517\u201328.","journal-title":"Eur J Endocrinol"},{"key":"BF03347076_CR13","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/archinte.166.14.1476","volume":"166","author":"VE Nielsen","year":"2006","unstructured":"Nielsen VE, Bonnema SJ, Boel-J\u00f8rgensen H, Grupe P, Heged\u00fcs L. Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign non-toxic nodular goiter: a prospective randomized double-blind trial. Arch Intern Med 2006, 166: 1476\u201382.","journal-title":"Arch Intern Med"},{"key":"BF03347076_CR14","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1210\/jc.2007-0501","volume":"92","author":"SJ Bonnema","year":"2007","unstructured":"Bonnema SJ, Nielsen VE, Boel-J\u00f8rgensen H, et al. Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial. J Clin Endocrinol Metab 2007, 92: 3424\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347076_CR15","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2967\/jnumed.108.060152","volume":"50","author":"S Fast","year":"2009","unstructured":"Fast S, Nielsen VE, Grupe P, Bonnema SJ, Hegedus L. Optimizing 131| uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study. J Nucl Med 2009, 50: 732\u20137.","journal-title":"J Nucl Med"},{"key":"BF03347076_CR16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1210\/jc.2004-1550","volume":"90","author":"VE Nielsen","year":"2005","unstructured":"Nielsen VE, Bonnema SJ, Boel-J\u00f8rgensen H, Veje A, Heged\u00fcs L. Recombinant human thyrotropin markedly changes the 131| kinetics during 131| therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial. J Clin Endocrinol Metab 2005, 90: 79\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347076_CR17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2214\/ajr.179.1.1790259","volume":"179","author":"SJ Bonnema","year":"2002","unstructured":"Bonnema SJ, Andersen PB, Knudsen DU, Heged\u00fcs L. MR imaging of large multinodular goiters: Observer agreement on volume versus observer disagreement on dimensions of the involved trachea. AJR Am J Roentgenol 2002, 179: 259\u201366.","journal-title":"AJR Am J Roentgenol"},{"key":"BF03347076_CR18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1210\/jcem-56-2-260","volume":"56","author":"L Heged\u00fcs","year":"1983","unstructured":"Heged\u00fcs L, Perrild H, Poulsen LR, et al. The determination of thyroid volume by ultrasound and its relationship to body weight, age, and sex in normal subjects. J Clin Endocrinol Metab 1983, 56: 260\u20133.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347076_CR19","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1210\/jc.2003-031641","volume":"89","author":"PS Hansen","year":"2004","unstructured":"Hansen PS, Brix TH, Sorensen TI, Kyvik KO, Heged\u00fcs L. Major genetic influence on the regulation of the pituitary-thyroid axis: a study of healthy Danish twins. J Clin Endocrinol Metab 2004, 89: 1181\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347076_CR20","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1210\/jc.2006-0226","volume":"91","author":"SJ Bonnema","year":"2006","unstructured":"Bonnema SJ, Bennedbaek FN, Veje A, Marving J, Hegedus L. Continuous methimazole therapy and its effecton the cure rate of hyperthyroidism using radioactive iodine: an evaluation by a randomized trial. J Clin Endocrinol Metab 2006, 91: 2946\u201351.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347076_CR21","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.2967\/jnumed.108.053934","volume":"49","author":"D Eterovic","year":"2008","unstructured":"Eterovic D, Antunovic Z, Markovic V, Grosev D. Planning of 131| therapy for Graves\u2019 disease based on the radiation dose to thyroid follicular cells. J Nucl Med 2008, 49: 2026\u201330.","journal-title":"J Nucl Med"},{"key":"BF03347076_CR22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1089\/cbr.2005.20.218","volume":"20","author":"M Grosso","year":"2005","unstructured":"Grosso M, Traino A, Boni G, et al. Comparison of different thyroid committed doses in radioiodine therapy for Graves\u2019 hyperthyroidism. Cancer Biother Radiopharm 2005, 20: 218\u201323.","journal-title":"Cancer Biother Radiopharm"},{"key":"BF03347076_CR23","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/00006231-200011000-00014","volume":"21","author":"SW Kok","year":"2000","unstructured":"Kok SW, Smit JW, de Craen AJ, Goslings BM, Eck-Smit BL, Romijn JA. Clinical outcome after standardized versus dosimetric radioiodine treatment of hyperthyroidism: an equivalence study. Nucl Med Commun 2000, 21: 1071\u20138.","journal-title":"Nucl Med Commun"},{"key":"BF03347076_CR24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1530\/eje.0.1410117","volume":"141","author":"B Catargi","year":"1999","unstructured":"Catargi B, Leprat F, Guyot M, Valli N, Ducassou D, Tabarin A. Optimized radioiodine therapy of Graves\u2019 disease: analysis of the delivered dose and of other possible factors affecting outcome. Eur J Endocrinol 1999, 141: 117\u201321.","journal-title":"Eur J Endocrinol"},{"key":"BF03347076_CR25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2265.1995.tb02039.x","volume":"43","author":"AE Jarl\u00f8v","year":"1995","unstructured":"Jarl\u00f8v AE, Heged\u00fcs L, Kristensen L\u00d8, Nygaard B, Hansen JM. Is calculation of the dose in radioiodine therapy of hyperthyroidism worthwhile? Clin Endocrinol (Oxf) 1995, 43: 325\u20139.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03347076_CR26","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1210\/jcem.87.3.8165","volume":"87","author":"S Andersen","year":"2002","unstructured":"Andersen S, Pedersen KM, Bruun NH, Laurberg P. Narrow individual variations in serum T4 and T3 in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 2002, 87: 1068\u201372.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347076_CR27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1365-2265.2000.01121.x","volume":"53","author":"N Knudsen","year":"2000","unstructured":"Knudsen N, B\u00fclow I, J\u00f8rgensen T, Laurberg P, Ovesen L, Perrild H. Goitre prevalence and thyroid abnormalities at ultrasonography: a comparative epidemiological study in two regions with slightly different iodine status. Clin Endocrinol (Oxf) 2000, 53: 479\u201385.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03347076_CR28","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1210\/jc.2006-2580","volume":"92","author":"P Vejbjerg","year":"2007","unstructured":"Vejbjerg P, Knudsen N, Perrild H, et al. Effect of a mandatory iodization program on thyroid gland volume based on individuals\u2019 age, gender, and preceding severity of dietary iodine deficiency: a prospective, population-based study. J Clin Endocrinol Metab 2007, 92: 1397\u2013401.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347076_CR29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-0038-1625205","volume":"44","author":"M Baczyk","year":"2005","unstructured":"Baczyk M, Junik R, Ziemnicka K, Sowinski J. Iodine prophylaxis intensification. Influence on radioiodine uptake and activity of 131| used in the treatment of hyperthyroid patients with Graves\u2019 disease. Nuklearmedizin 2005, 44: 197\u20139.","journal-title":"Nuklearmedizin"},{"key":"BF03347076_CR30","first-page":"3684","volume":"167","author":"A Vej-Hansen","year":"2005","unstructured":"Vej-Hansen A, Nygaard B. [Iodine uptake and the effect of radioiodine treatment\u2014status after the addition of iodine to salt]. Ugeskr Laeger 2005, 167: 3684\u20137.","journal-title":"Ugeskr Laeger"},{"key":"BF03347076_CR31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1530\/eje.0.1440461","volume":"144","author":"S Andersen","year":"2001","unstructured":"Andersen S, Pedersen KM, Pedersen IB, Laurberg P. Variations in urinary iodine excretion and thyroid function. A 1-year study in healthy men. Eur J Endocrinol 2001, 144: 461\u20135.","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03347076\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:50:04Z","timestamp":1565311804000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03347076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["BF03347076"],"URL":"https:\/\/doi.org\/10.1007\/bf03347076","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,9]]}}}